SequelSEC

MetaVia Inc. MTVA

Pharmaceutical Preparations · CIK 0001638287 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
Unavailable
Fiscal year ended 2025-12-31
Operating income
-$13.71M
Fiscal year ended 2025-12-31
Free cash flow
-$15.70M
Fiscal year ended 2025-12-31

MetaVia Inc. (MTVA) reported net income of -$12.97M for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from MetaVia Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

MetaVia Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
RevenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating income-$13.71M-$28.81M-$15.89M-$19.63M-$15.30M-$29.72M-$20.18M-$15.49M-$33.12M-$14.70M
Net income-$12.97M-$27.59M-$12.47M-$13.97M-$15.28M-$29.68M-$21.31M-$15.53M-$33.42M-$14.59M
Research & development$6.80M$21.55MUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 1.77MUnavailableshares 5.07MUnavailableUnavailableshares 16.22MUnavailableUnavailableUnavailableUnavailable
Pretax income-$12.97M-$27.59M-$12.47M-$13.97M-$15.28M-$29.68M-$21.31M-$15.53M-$33.42M-$14.59M
Income tax expense$0$0$0$0$0$0$0$0$0$0
Diluted EPS$-7.35$-39.13$-2.46$-43.42$-19.81$-1.83UnavailableUnavailableUnavailableUnavailable
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrative$6.91M$7.26M$6.73M$8.64M$8.75M$7.85M$2.70M$1.60M$10.44M$5.96M
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

MetaVia Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Cash & equivalents$10.28M$16.02M$22.44M$33.36M$16.39M$10.09M$13.91M$2.84M$18.47M$24.03M
Total assets$11.12M$16.26M$22.78M$33.53M$16.80M$10.97M$14.47M$3.82M$19.02M$24.75M
Current assets$10.88M$16.07M$22.51M$33.53M$16.58M$10.68M$14.12M$3.81M$19.01M$24.75M
Total liabilities$5.79M$8.33M$6.10M$11.78M$2.20M$3.76M$2.18M$360.00K$15.08M$4.12M
Current liabilities$5.65M$8.27M$5.96M$11.78M$2.16M$3.70M$2.08M$219.00K$6.39M$4.12M
Total equity incl. NCI$5.33M$7.93M$16.68M$21.75M$14.60M$7.20M$12.29M-$13.29M$25.00K$20.63M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$16.75MUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$1.06M$3.88M$821.00K$708.00K$830.00K$2.58M$638.00K$170.00K$4.02M$2.01M

Cash flow

MetaVia Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Operating cash flow-$15.70M-$24.71M-$10.80M-$11.71M-$15.13M-$10.76M-$7.04M-$14.45M-$26.90M-$11.04M
Capital expenditures$2.00K$8.00K$50.00KUnavailable$3.00K$4.00K$214.00K$3.00KUnavailableUnavailable
Investing cash flow-$2.00K-$8.00K-$50.00K$8.00K-$586.00K$69.00K-$6.06M-$3.00KUnavailableUnavailable
Financing cash flow$9.96M$18.30M-$80.00K$28.68M$22.03M$6.86M$24.17M$17.25M$21.34M$31.46M
Net change in cashUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$481.00K-$5.56M$20.41M
Stock-based compensation$411.00K$538.00K$222.00K$854.00K$662.00K$699.00K$118.00K$4.13M$5.27M$1.72M
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Derived

MetaVia Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Free cash flow-$15.70M-$24.72M-$10.85MUnavailable-$15.14M-$10.77M-$7.25M-$14.45MUnavailableUnavailable
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current ratio1.93x1.94x3.78x2.85x7.69x2.89x6.78x17.39x2.97x6.00x
Revenue YoY growthUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Net marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open MTVA in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-14View SEC filing
10-K · Filed 2026-03-26View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-14View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Reconciliation checks needing review

2 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

cash flow reconciliationreview2018-12-31

Operating, investing and financing flows differ from the reported change in cash by 2314000, beyond tolerance 1000000.

balance equationreview2017-12-31

Difference 3916000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.